Fulcrum Therapeutics, Inc. (FULC) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
FULC currently has 66.6M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 23.46% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 27, 2026 |
10-Q filing | 66.6M shares outstanding |
67M | 0 |
| Oct 29, 2025 |
10-Q filing | 54.1M shares outstanding |
54M | 0 |
| Jul 29, 2025 |
10-Q filing | 54.1M shares outstanding |
54M | 0 |
| May 01, 2025 |
10-Q filing | 54.0M shares outstanding |
54M | 0 |
| Feb 25, 2025 |
10-K filing | 54.0M shares outstanding |
54M | 0 |
| Nov 13, 2024 |
10-Q filing | 53.9M shares outstanding |
54M | 0 |
| Jul 31, 2024 |
10-Q filing | 62.2M shares outstanding |
62M | 0 |
| May 13, 2024 |
10-Q filing | 62.2M shares outstanding |
62M | 0 |
| Feb 27, 2024 |
S-3 filing: The company is filing an S-3 to offer and sell debt securities, common stock, preferred stock and depositary shares from time to time in one or more offerings, up to an aggregate value of $350,000,000. |
62M | 0 |
| Feb 27, 2024 |
10-K filing | 61.9M shares outstanding |
62M | 0 |
| Nov 07, 2023 |
10-Q filing | 61.8M shares outstanding |
62M | 0 |
| Aug 03, 2023 |
10-Q filing | 61.8M shares outstanding |
62M | 0 |
| May 15, 2023 |
10-Q filing | 61.8M shares outstanding |
62M | 0 |
| Mar 09, 2023 |
10-K filing | 61.8M shares outstanding |
62M | 0 |
| Nov 08, 2022 |
10-Q filing | 52.1M shares outstanding |
52M | 0 |
| Aug 11, 2022 |
10-Q filing | 41.0M shares outstanding |
41M | 0 |
| May 09, 2022 |
10-Q filing | 40.8M shares outstanding |
41M | 0 |
| Mar 03, 2022 |
10-K filing | 40.6M shares outstanding |
41M | 0 |
| Mar 03, 2022 |
POS AM filing: Issuer intends to offer and sell securities from time to time in one or more offerings, up to an aggregate value of $250,000,000. |
41M | 0 |
| Nov 04, 2021 |
10-Q filing | 40.5M shares outstanding |
41M | 0 |
| Aug 10, 2021 |
10-Q filing | 32.7M shares outstanding |
33M | 0 |
| May 06, 2021 |
10-Q filing | 32.7M shares outstanding |
33M | 0 |
| Mar 04, 2021 |
10-K filing | 32.7M shares outstanding |
33M | 0 |
| Nov 10, 2020 |
10-Q filing | 27.5M shares outstanding |
27M | 290K |
| Aug 11, 2020 |
10-Q filing | 27.5M shares outstanding |
27M | 300K |
| Aug 11, 2020 |
POS AM filing: This POS AM filing relates to the resale of common stock by selling stockholders; the company will not receive any proceeds from the offering. |
23M | 4.4M |
| Aug 11, 2020 |
S-3 filing: The filing is for a shelf offering of debt securities, common stock, preferred stock, and depositary shares up to an aggregate amount of $250,000,000, including an at-the-market offering of common stock with an aggregate offering price of up to $75,000,000. |
27M | 300K |
| May 13, 2020 |
10-Q filing | 23.4M shares outstanding |
23M | 0 |
| Mar 05, 2020 |
10-K filing | 23.4M shares outstanding |
23M | 0 |